Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature

Table 5 Demographics of non-human immunodeficiency virus infected patients with autoimmune hepatitis

Country	n	Female (%)	Age at onset	Cirrhosis1	Disease onset	ANA+	ASMA+	IgG > ULN
Asia-Pacific
South Korea[10]	4085	86	60-69	32.3%	-	-	-	-
Japan[46]	1682	87	60-69	6.7% (P)	11.7% acute hepatitis 79.6% chronic hepatitis	90.7%	40.9%	n/a
South Korea[47]	343	-	-	23%	46.4% acute onset 30.6% asymptomatic	94.2%	23.0%	78.2%
New Zealand[15]	138	71	50-59	36% (P, R)	-	56%	57%	97%
Israel[13]	100	95	48	22.3% (P)	35% asymptomatic	91%	55%	n/a
Taiwan[7]	48	77	58	35.4% (P)	12.5% asymptomatic 41.7% acute onset 45.8% insidious onset	97.8%	18.2%	72.9%
Japan[14]	48	-	-	8.3% (C+R)	68.8% acute onset 31.2% chronic onset	100%	22.9%	79.2%
Australia[12]	42	74	53	24% (P)	-	n/a	65.8%	n/a
India[8]	38	89	30	34.2% (C±P)	13.1% acute hepatitis 39.4% acute onset 50% chronic onset	39.4%	63.1%	n/a
Singapore[9]	24	92	63	42% (C)	2/3 insidious onset	79.2%	20.8%	n/a
Brunei Darussalam[11]	19	79	52	21.1% (P)	53% asymptomatic	100%	47.4%	n/a
Europe and America
Denmark[4]	1721	72	70	28.3% (P)	-	-	-	-
Netherlands[5]	1313	78	Middle age	12% (P)	-	49%	58%	83%
Finland[3]	887	76	55-64	-	-	-	-	-
Sweden[2]	634	73	50-60	28.1%	-	-	-	-
Alaska[48]	71	-	-	-	-	79.1%	60%	66%
United States (Alaska)[17]	49	92	52	0%	34.7% acute hepatitis 65.3% asymptomatic	-	-	-
Norway[16]	25	80	68	28% (P)	-	68%	40%	n/a
Spain[6]	19	95	45-54	-	-	-	-	-

¹(P, C, R) – Diagnosis of cirrhosis at AIH presentation was made by pathological, clinical or radiological features, respectively.